ES2039480T3 - Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa. - Google Patents

Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.

Info

Publication number
ES2039480T3
ES2039480T3 ES198787850382T ES87850382T ES2039480T3 ES 2039480 T3 ES2039480 T3 ES 2039480T3 ES 198787850382 T ES198787850382 T ES 198787850382T ES 87850382 T ES87850382 T ES 87850382T ES 2039480 T3 ES2039480 T3 ES 2039480T3
Authority
ES
Spain
Prior art keywords
active substance
pharmaceutically active
dosage form
oral administration
liquid dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787850382T
Other languages
English (en)
Inventor
Kjell Johan Mattsson
Alf Gunnar Martin Nicklasson
Rolf Ivar Sjoqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Application granted granted Critical
Publication of ES2039480T3 publication Critical patent/ES2039480T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA FORMA DE DOSIFICACION PARA ADMINISTRACION ORAL DE UNA SUSTANCIA FARMACEUTICAMENTE ACTIVA, CARACTERIZADA PORQUE INCLUYE UNA SUSTANCIA FARMACEUTICAMENTE ACTIVA ENCAPSULADA O EMBEBIDA EN UN LIQUIDO NO ACUOSO FARMACEUTICAMENTE ACEPTABLE.
ES198787850382T 1986-12-22 1987-12-07 Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa. Expired - Lifetime ES2039480T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance

Publications (1)

Publication Number Publication Date
ES2039480T3 true ES2039480T3 (es) 1993-10-01

Family

ID=20366721

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787850382T Expired - Lifetime ES2039480T3 (es) 1986-12-22 1987-12-07 Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.

Country Status (17)

Country Link
US (1) US5085868A (es)
EP (1) EP0273890B1 (es)
JP (1) JP2778030B2 (es)
AT (1) ATE87471T1 (es)
AU (1) AU609753B2 (es)
CA (1) CA1317883C (es)
DE (1) DE3785167T2 (es)
DK (1) DK668787A (es)
ES (1) ES2039480T3 (es)
FI (1) FI94923C (es)
GR (1) GR3007542T3 (es)
HK (1) HK66396A (es)
IE (1) IE60149B1 (es)
IL (1) IL86607A (es)
NO (1) NO177177C (es)
PH (1) PH25287A (es)
SE (1) SE8605515D0 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476447A (en) * 1968-03-28 1969-11-04 Westinghouse Electric Corp Self-aligning hydrostatic bearing
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
ES2057021T3 (es) * 1988-06-07 1994-10-16 Abbott Lab Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5306507A (en) * 1992-03-26 1994-04-26 Mallinckrodt Specialty Chemicals Company Process and composition containing pamabrom and pyrilamine maleate
US5464625A (en) * 1992-05-08 1995-11-07 Monell Chemical Senses Center Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
EP0664701B1 (en) * 1992-10-16 1997-09-10 Glaxo Group Limited Taste-masking compositions of ranitidine
JP2949448B2 (ja) * 1992-11-30 1999-09-13 ケーヴィ ファーマセチカル カンパニー 味を隠された医薬材料
WO1997018245A1 (en) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complex of naproxen and beta-cyclodextrin
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
SE9702338D0 (sv) * 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
ES2601855T3 (es) * 1998-11-25 2017-02-16 Cima Labs Inc. Comprimido de liberación rápida con núcleo recubierto que contiene el fármaco y capa circundante de enmascaramiento del sabor
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
CN1189159C (zh) * 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
JP4698950B2 (ja) 2002-04-09 2011-06-08 フラメル・テクノロジー アモキシシリンの改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
WO2004004682A2 (en) * 2002-07-02 2004-01-15 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20050037979A1 (en) * 2003-06-05 2005-02-17 Ping Jeffrey H. Tannate compositions and methods of use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
GB201804621D0 (en) 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation
US20230312842A1 (en) * 2022-02-08 2023-10-05 Fujifilm Business Innovation Corp. Cellulosic particle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
ES416148A1 (es) * 1972-12-26 1976-06-01 Willian H Rorer Inc Un procedimiento para preparar particulas antiacidas mejo- radas.
JPS5420572B2 (es) * 1973-04-27 1979-07-24
US4292028A (en) * 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS6136217A (ja) * 1984-07-27 1986-02-20 Sankyo Co Ltd 経口投与用持効性製剤
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JPS6317821A (ja) * 1986-07-11 1988-01-25 Taisho Pharmaceut Co Ltd 矯味経口製剤
NZ221411A (en) * 1986-08-11 1989-10-27 Innovata Biomed Ltd Pharmaceutical compositions containing microcapsules and a surfactant

Also Published As

Publication number Publication date
US5085868A (en) 1992-02-04
FI875645A0 (fi) 1987-12-21
NO177177C (no) 1995-08-02
AU8199187A (en) 1988-06-23
FI94923C (fi) 1995-11-27
SE8605515D0 (sv) 1986-12-22
EP0273890B1 (en) 1993-03-31
PH25287A (en) 1991-04-30
AU609753B2 (en) 1991-05-09
JPS63166838A (ja) 1988-07-11
IE60149B1 (en) 1994-06-15
HK66396A (en) 1996-04-26
FI94923B (fi) 1995-08-15
CA1317883C (en) 1993-05-18
ATE87471T1 (de) 1993-04-15
DK668787A (da) 1988-06-23
IE873306L (en) 1988-06-22
DE3785167T2 (de) 1993-07-15
NO874960L (no) 1988-06-23
NO874960D0 (no) 1987-11-27
DE3785167D1 (de) 1993-05-06
GR3007542T3 (es) 1993-08-31
JP2778030B2 (ja) 1998-07-23
IL86607A (en) 1992-03-29
EP0273890A1 (en) 1988-07-06
NO177177B (no) 1995-04-24
DK668787D0 (da) 1987-12-18
FI875645L (fi) 1988-06-23

Similar Documents

Publication Publication Date Title
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
FI863074A7 (fi) Farmaseuttisesti aktiivisten aineiden rakeinen, hidasluovutteinen muoto.
EP0230575A3 (de) Arzneimittel mit Antitumorwirkung das Hexadecylphosphocholin enthält
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
ES554169A0 (es) Metodo de fabricacion de un dispositivo medico para la administracion de una droga insoluble en grasas, altamente ionizadas.
IT8819591A0 (it) Prodotto comprendente un composto organico del silicio combinato con una sostanza cosmeticamente attiva.
ES2009251A6 (es) Un metodo de obtencion de una composicion anticonceptiva para la mujer
ZA739543B (en) Free-flowing, directly tablettable, pharmaceutically active substances
AU7200387A (en) Device for self-administration of physiologically active substances, with prevention of overdosing
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
ES552145A0 (es) Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
FI831687A7 (fi) Farmaseuttisia seoksia, jotka sisältävät useampia aktiivisia aineosia.
DE69104608D1 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
IT8220549A0 (it) Dispositivo sanitario per una crio-farmaco terapia topica sintomatica di malattie benigne ano-rettali, in particolari di emorroidi.
DE3380165D1 (en) Analgesic combinations
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
IT8349163A0 (it) 5h-dibenz/b,f/azepin-5-carbossamidi loro prodotti intermedi, preparati farmaceutici che le contengono, procedimento per produrle e loro impiego
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8348726A0 (it) Composti di amminoimidazolile, procedimenti per la loro produzione e preparati farmaceutici che contengono questi composti

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 273890

Country of ref document: ES